- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Long-term Study of Dexamethasone Cipecilate (NS-126C): A Steroid Nasal Spray in Perennial Allergic Rhinitis
-
- Okubo Kimihiro
- Nippon Medical School
-
- Okuda Minoru
- Japan Allergy and Asthma Clinic
-
- Hamada Chikuma
- Tokyo University of Science
Bibliographic Information
- Other Title
-
- 鼻噴霧用ステロイド薬デキサメタゾンシペシル酸エステル(NS‐126C)の通年性アレルギー性鼻炎における長期投与試験
- 薬物 鼻噴霧用ステロイド薬デキサメタゾンシペシル酸エステル(NS-126C)の通年性アレルギー性鼻炎における長期投与試験
- ヤクブツ ハナ フンムヨウ ステロイドヤク デキサメタゾンシペシルサン エステル NS 126C ノ ツウネン セイ アレルギーセイ ビエン ニ オケル チョウキ トウヨ シケン
Search this article
Description
A placebo-controlled randomized double-blind parallel-group comparison study of dexamethasone cipecilate (NS-126C) steroid nasal spray, conducted in those with perennial allergic rhinitis, clarified efficacy and safety of drug administration at 400 μg once a day for 12 weeks.<br> Of the 165 subjects in the Full Analysis Set (FAS) (NS-126C: 133; placebo: 32), total nasal symptom scores for sneezing, rhinorrhea, and nasal congestion in the NS-126C group improved significantly over the placebo group throughout the study with efficacy sustained for 12 weeks (p<0.001 to 0.024). Individual Scores for sneezing, rhinorrhea, and nasal congestion also improved more significantly in the NS-126C group over the placebo group throughout the study.<br> A total quality of life (QOL) study score based on the Japan Rhinoconjunctivitis Quality of Life Questionnaire (JRQLQ) was significantly higher in the NS-126C group than in the placebo group (p=0.001 to 0.017) throughout the study.<br> There was no significant difference in adverse event or drug reaction incidences between groups. Neither adverse events with an increase in incidence and no delayed adverse events due to long-term administration was seen. Plasma cortisol was unchanged over time, indicating the absence of an effect on adrenal cortical function. No abnormality was detected on the nasal mucociliary function test. Nasal discomfort, pharyngeal discomfort, and positive reaction to the nasal fungal test were observed in one patient per group as local adverse drug reactions.<br> Findings thus showed that NS-126C is a safe steroid nasal spray with long-acting efficacy improving QOL in patients with allergic rhinitis.<br>
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 103 (5), 489-502, 2010
The Society of Practical Otolaryngology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679239233920
-
- NII Article ID
- 10026217565
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 10689926
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed